Clinical Trials Logo

Filter by:
NCT ID: NCT02389413 Completed - Alzheimer's Disease Clinical Trials

Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease

SAPHIR
Start date: March 2015
Phase: Phase 2
Study type: Interventional

The aim of this study is to evaluate the safety, tolerability and preliminary efficacy of PQ912 in subjects with Mild Cognitive Impairment (MCI) due to Alzheimers Disease (AD) or mild dementia due to AD.

NCT ID: NCT02389231 Completed - Clinical trials for Autoimmune Hemolytic Anemia

Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment

ANEMIL
Start date: May 17, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The investigators have demonstrated that the mean percentage of circulating CD8+ regulatory T (CD8 Tregs) cells is significantly higher in patients with warm hemolytic anemia (wAHAI) in remission than in controls and is correlated to hemoglobin levels. In vitro, low dose of interleukine-2 (IL2) induce the expansion of CD8 Tregs. The objective is to demonstrate that, over a 9 week treatment period; low doses of IL2 can induce the expansion of CD8Tregs in patients with active wAHAI.

NCT ID: NCT02389166 Completed - Respiratory Failure Clinical Trials

Optiflow in Sequential Non-Invasive Ventilation

VNI-HD
Start date: June 25, 2015
Phase: N/A
Study type: Interventional

Background : Patient with hypoxemic respiratory failure treated with NIV receive between NIV session oxygen therapy. Gaz exchange disorder with a decrease of the ratio between Partial Pressure of Arterial Oxygen (PaO2) and Inspired Fraction of Oxygen (FIO2) are noticed when NIV is stopped at the end of the session du to alveolar derecruitment Optiflow is a high flow oxygen delivery system used a heated humidifier and heated breathing circuit. In observational studies, Optiflow increase oxygenation of patients with hypoxemic respiratory failure. Oxygenation is better than under high-concentration mask and work of breathing is reduced. The aim of the study is to compare in acute hypoxemic respiratory failure, optiflow to oxygen therapy under high-concentration mask, on patients oxygenation between NIV sessions (measured as the difference between PaO2/FiO2 ratio at the beginning and at the end of the session), during the first two NIV sessions Study design : Prospective, randomized, controlled, multicentric, open clinical trial with two groups: - control group with conventional clinical management, oxygen therapy and sequential used of NIV - Optiflow group with high flow oxygen delivery system, conventional clinical management and sequential used of NIV for a period of 36 hours at least. Number of subjects: 100 (50 patients per group) patients admitted in intensive Care Unit for hypoxemic respiratory failure.

NCT ID: NCT02388295 Completed - Clinical trials for Multiple System Atrophy, MSA

AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

Start date: April 27, 2015
Phase: Phase 2
Study type: Interventional

AZD3241 myeloperoxidase (MPO) inhibitor trial is assessing safety and tolerability, randomized trial, in patients with Multiple System Atrophy.

NCT ID: NCT02387138 Completed - Digestive Cancer Clinical Trials

A Trial Assessing Several Schedules of Oral S-1 in Combination With a Fixed Dose of Oxaliplatin and Irinotecan

SIRINOX
Start date: April 2014
Phase: Phase 1
Study type: Interventional

This study is to determine the Maximal Tolerated Dose (MTD), the Dose Limitant Toxicities (DLTs) and the safety profile of S-1 combined with fixed doses of Irinotecan (SIRI schedule) and fixed doses of Irinotecan and Oxaliplatin (SIRINOX schedule).

NCT ID: NCT02387047 Completed - Phobic Disorders Clinical Trials

Validity of a Self-administered Questionnaire to Screen Phobia of Falling in the Elderly

PACTE-q
Start date: November 2014
Phase: N/A
Study type: Observational

The aim of this study is to determine the validity of a self-questionnaire detecting seniors phobia of falling living at home. A prospective monocentric observational study compares in a blind way the presence of Diagnostic and Statistical Manual of Mental Disorders fourth edition (DSM-IV) criteria for specific phobia, considered as the gold standard to the score obtained at the detecting questionnaire for ≥70 years old seniors suspected of phobia of falling and attending geriatric day hospital at the Bretonneau hospital (APHP, Paris).

NCT ID: NCT02386969 Completed - Neuropathic Pain Clinical Trials

Repetitive Transcranial Magnetic Stimulation in Central Neuropathic Pain

Start date: November 11, 2015
Phase: N/A
Study type: Interventional

The repetitive transcranial magnetic stimulation (rTMS) is used in pain treatment for several years. The aim of the study is to assess, in a rigorous scientific protocol, analgesic effect of the neuronavigated rTMS assisted by robotic arm on chronic neuropathic painful subjects. The crossover study is randomized, double blinded and controlled (sham rTMS) and it includes a large homogeneous population suffering of central neuropathic pain.

NCT ID: NCT02386787 Completed - Anesthesia Clinical Trials

Ultrasound Assessment of Gastric Content for Semi Emergency Surgery

ECHO-GAST
Start date: May 2014
Phase: N/A
Study type: Interventional

Aspiration of gastric content is a rare but serious complication of anesthesia. In this context, preoperative fasting for elective surgery is well defined. In an emergency situation, international guidelines recommend rapid sequence of anesthesia to reduce the risk of aspiration. In semi emergency situation, there is no consensus about the anesthetic procedure even if a preoperative fasting has been observed due to uncertainty of gastric emptying related to stress or painful condition. The choice of anesthesia induction technique depends mainly on the anesthetist. Ultrasonography is a non invasive bedside tool that can provide reliable quantitative information about the volume of gastric content.

NCT ID: NCT02386774 Completed - Blepharitis Clinical Trials

Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa

INNOV-EYE
Start date: March 21, 2016
Phase: N/A
Study type: Interventional

In vivo confocal microscopy (IVCM) used in tertiary care ophthalmology centers is performed with two reflectance microscopes attached on a mounting with limited movement along the XYZ axes. Consequently, ocular diseases in the central area have been described (mostly cornea and adjacent conjunctiva). Two dermatology IVCM (an handheld small IVCM and a multifluorescent one) present significant innovations that the investigators want to assess in ophthalmology for the diagnosis of conjunctiva, cornea, eyelid and lachrymal tract diseases. The handheld IVCM have unlimited degrees of freedom and a small diameter objective. It could dramatically increase the area accessible to IVCM (whole conjunctiva, eyelids, proximal lachrymal tract) (part 1 of the present study). The fluorescent IVCM allows the use of a wide range of fluorescent markers liable to increase the specificity of the diagnosis by revealing staining patterns corresponding to a specific disease and not to others (part 2 of the study)

NCT ID: NCT02386397 Completed - Digestive Cancer Clinical Trials

Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer

BREGO
Start date: September 2014
Phase: Phase 1/Phase 2
Study type: Interventional

This study is to determine the Regorafenib Dose (RD) for the phase II trial of Regorafenib administered in combination with mGEMOX in patients with advanced biliary tract cancer.